Trial Condition(s):
Thromboembolism
SALTO - Epidemiological study on compliance and treatment satisfaction (SALTO)
Bayer Identifier:
14343
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
Patients that are on total knee/hip replacement initiate prophylaxis treatment on the hospital ground. Once they leave the hospital, as outpatients they continue with the treatment at least during two consecutive weeks. Patients will be instructed to follow treatment recommendations (either LMWH or oral treatment, at physician discretion) and to come back to the surgeon after that period. At that visit, the Treatment Satisfaction Questionaire with Medication (TSQM) test as well as the Moriski-Green Questionaire (measures compliance with medication) will be answer by the patient. TSQM is an self administered validated scale (validated also in spanish) that measures in a generic way the treatment satisfaction to a treatment. Morinski-Green test will be used to measure the compliance degree on medication.
Inclusion Criteria
- Patients in antithrombotic prophylaxis treatment after total knee/hip replacement. This is an epidemiological study where the patients to be included will be those that are treated with antithrombotics as out-patients in real life conditions.
Exclusion Criteria
- Patients who has been previously treated with injectable antithrombotic treatments. - Diabetic patients treated with insulin. - Patients who do not sign Informed Consent Form.
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Investigative Site Many Locations, Spain | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Compliance and treatment satisfaction in Prophylaxis of postsurgical thromboembolism
Trial Type:
Observational
Intervention Type:
Behavioral
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- To measure the Treatment Satisfaction with medication through the self administered scale TSQM.Timeframe: 2 weeks
Secondary Outcome
- To measure compliance with medication and the relationship with satisfaction through the Moriski-Green QuestionaireTimeframe: 2 weeks
Additional Information
Copyright © Bayer
Powered by
